Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $6.0500 (-1.47%) ($6.0500 - $6.0500) on Wed. Oct. 6, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.24% (three month average) | RSI | 45 | Latest Price | $6.0500(-1.47%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -0.9% a day on average for past five trading days. | Weekly Trend | AUTL declines -1.8% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) XBI(52%) ARKG(48%) IBUY(48%) IWO(48%) ARKK(47%) | Factors Impacting AUTL price | AUTL will decline at least -2.12% in a week (0% probabilities). VIXM(-34%) VXX(-30%) SHY(-21%) TLT(-19%) BNDX(-16%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.12% (StdDev 4.24%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-1.92(-131.74%) | Resistance Level | $6.57 | 5 Day Moving Average | $6.36(-4.87%) | 10 Day Moving Average | $6.46(-6.35%) | 20 Day Moving Average | $6.57(-7.91%) | To recent high | -17.9% | To recent low | 13.8% | Market Cap | $316m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |